Cerebrovascular-Reactivity Mapping Using MRI: Considerations for Alzheimer's Disease.

about

Cerebrovascular-Reactivity Mapping Using MRI: Considerations for Alzheimer's Disease.

Item

http://www.wikidata.org/entity/Q55252662

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Cerebrovascular-Reactivity Mapping Using MRI: Considerations for Alzheimer's Disease.

@en

Cerebrovascular-Reactivity Mapping Using MRI: Considerations for Alzheimer's Disease.

@nl

type

Item

label

Cerebrovascular-Reactivity Mapping Using MRI: Considerations for Alzheimer's Disease.

@en

Cerebrovascular-Reactivity Mapping Using MRI: Considerations for Alzheimer's Disease.

@nl

prefLabel

Cerebrovascular-Reactivity Mapping Using MRI: Considerations for Alzheimer's Disease.

@en

Cerebrovascular-Reactivity Mapping Using MRI: Considerations for Alzheimer's Disease.

@nl

P1476

Cerebrovascular-Reactivity Mapping Using MRI: Considerations for Alzheimer's Disease.

@en

P2093

J J Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

Serum response factor and myocardin mediate arterial hypercontractility and cerebral blood flow dysregulation in Alzheimer's phenotype.

On the Regulation of the Blood-supply of the Brain

Impaired vascular-mediated clearance of brain amyloid beta in Alzheimer's disease: the role, regulation and restoration of LRP1

Roles of vascular and metabolic components in cognitive dysfunction of Alzheimer disease: short- and long-term modification by non-genetic risk factors

Nox2-derived radicals contribute to neurovascular and behavioral dysfunction in mice overexpressing the amyloid precursor protein.

Cerebrovascular reactivity to carbon dioxide in Alzheimer's disease.

Cerebrovascular reactivity mapping: an evolving standard for clinical functional imaging.

Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience.

P304

170

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FNAGI.2018.00170

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jean J Chen

P577

2018-06-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29922153

http://www.w3.org/2001/XMLSchema#string

P932

5996106

http://www.w3.org/2001/XMLSchema#string